CoChat

Gut microbiota: a promising target against cardiometabolic diseases

Open access
Warmbrunn, Moritz V., Herrema, Hilde, Aron-Wisnewsky, Judith, Soeters, Maarten R., Van Raalte, Daniel H., Nieuwdorp, Max · 2020 · Expert Review of Endocrinology & Metabolism
Cited by 47

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Abstract

Introduction: Cardiometabolic diseases (CMD) are a group of interrelated disorders such as metabolic syndrome, type 2 diabetes mellitus and cardiovascular diseases (CVD). As the prevalence of these diseases increases globally, efficient new strategies are necessary to target CMD and modifiable risk factors. In the past decade, evidence has accumulated regarding the influence of gut microbiota (GM) on CMD, providing new targets for therapeutic interventions.Areas covered: This narrative review discusses the pathophysiologic link between CMD, GM, and potential microbiota-based targets against atherosclerosis and modifiable risk factors for atherosclerosis. Low-grade inflammation can be induced through GM and its derived metabolites. CMD are influenced by GM and microbiota-derived metabolites such as short-chain fatty acids (SCFA), secondary bile acids, trimethylamine N-oxide (TMAO), and the composition of GM can modulate host metabolism. All of the above can lead to promising therapeutic targets.Expert opinion: Most data are derived from animal models or human association studies; therefore, more translational and interventional research in humans is necessary to validate these promising findings. Reproduced findings such as aberrant microbiota patterns or circulating biomarkers could be targeted depending on individual metabolic profiles, moving toward personalized medicine in CMD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/17446651.2020.1720511

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Cited by

See all 47

Metadata

Authors
Warmbrunn, M. V., Herrema, H., Aron-Wisnewsky, J., Soeters, M. R., Van Raalte, D. H., & Nieuwdorp, M.
Venue
Expert Review of Endocrinology & Metabolism
Published
2020-01-02
Volume
15
Issue
1
Pages
13-27
ISSN
  • 1744-6651 (ISSN-L)
  • 1744-8417
OpenAlex
W3007372128
Cited by
47
References
61
FWCI
2.21
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gut microbiota: a promising target against cardiometabolic diseases. https://app.cochat.ai/papers/10.1080/17446651.2020.1720511
The paper
Warmbrunn, M. V., Herrema, H., Aron-Wisnewsky, J., Soeters, M. R., Van Raalte, D. H., & Nieuwdorp, M. (2020). Gut microbiota: a promising target against cardiometabolic diseases. Expert Review of Endocrinology & Metabolism. https://doi.org/10.1080/17446651.2020.1720511

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.